ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

0RDB Oryzon Genomics Sa

2.725
0.00 (0.00%)
Last Updated: 20:00:00
Delayed by 15 minutes

Oryzon Genomics Financial Summary

The current 0RDB market cap is 166.54M. The company's latest EPS is EUR -0.0549 and P/E is -49.54.

Year End December 30 2023 20192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Revenue 42k98k168k255k153k
Operating Income -3.83M-4.29M-7.01M-5.49M-4.55M
Net Income -3.68M-3.4M-4.69M-4.23M-3.35M
Year End December 30 2023 20192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Assets 80.09M94.11M95.38M103.7M106.9M
Total Liabilities 18.97M18.18M24.12M31.13M25.13M
Total Equity 61.13M75.93M71.26M72.57M81.78M

Cash Flow

Year End December 30 2023 20192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Operating -3.93M-4.82M-3.63M-1.85M-575k
Investing -9.58M-9.08M-11.72M-14.27M-14.5M
Financing 14.26M18.38M4.12M8.71M6.02M
Market Cap 166.54M
Price to Earnings Ratio -49.54
Price to Sales Ratio 1.09k
Price to Cash Ratio 13.57
Price to Book Ratio 2.03
Dividend Yield -

Share Statistics

Shares Outstanding 61.12M
Average Volume (1 week) 7
Average Volume (1 Month) 24
52 Week Change 0.00%
52 Week High 2.725
52 Week Low 2.725
Spread (Intraday) 0 (0%)

Company Info

Company Name Oryzon Genomics Sa
Address carrera de san jeronimo 15
madrid, community of madrid 08940
Website https://www.oryzon.com
Industry med, dental, hosp eq-whsl (5047)